Your browser doesn't support javascript.
loading
N-terminal α Dystroglycan (αDG-N): A Potential Serum Biomarker for Duchenne Muscular Dystrophy.
Crowe, Kelly E; Shao, Guohong; Flanigan, Kevin M; Martin, Paul T.
Affiliation
  • Crowe KE; Graduate Program in Molecular Cellular and Developmental Biology, The Ohio State University, Columbus, OH, USA.
  • Shao G; Center for Gene Therapy, The Research Institute at Nationwide Children's Hospital, Columbus, OH, USA.
  • Flanigan KM; Center for Gene Therapy, The Research Institute at Nationwide Children's Hospital, Columbus, OH, USA.
  • Martin PT; Department of Pediatrics, The Ohio State University College of Medicine, Columbus, OH, USA.
J Neuromuscul Dis ; 3(2): 247-260, 2016 05 27.
Article in En | MEDLINE | ID: mdl-27854211
Subject(s)
Key words
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Muscular Dystrophy, Duchenne / Dystroglycans Type of study: Observational_studies / Prognostic_studies / Risk_factors_studies Limits: Animals / Female / Humans / Male Language: En Journal: J Neuromuscul Dis Year: 2016 Document type: Article Affiliation country: Country of publication:
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Muscular Dystrophy, Duchenne / Dystroglycans Type of study: Observational_studies / Prognostic_studies / Risk_factors_studies Limits: Animals / Female / Humans / Male Language: En Journal: J Neuromuscul Dis Year: 2016 Document type: Article Affiliation country: Country of publication: